Regeneron Pharmaceuticals REGN
Jason Pitofsky (Officer) plans to sell 2,036 REGN shares, about $1.6M
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001969223-26-000127
- Approximate sale date: Feb 9, 2026
- Broker: UBS Financial Services, Inc.
- Shares acquired by: Exercise of Stock Options; Restricted Stock Award
- 10b5-1 plan adopted: Nov 10, 2025
All of Jason Pitofsky's insider filings, holdings and planned sales
Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):
- Sold 20 shares at $775.95 on Feb 9, 2026 · Form 4
- Sold 521 shares at $776.43 on Feb 9, 2026 · Form 4
- Sold 391 shares at $777.51 on Feb 9, 2026 · Form 4
- Sold 563 shares at $778.35 on Feb 9, 2026 · Form 4
- Sold 205 shares at $779.56 on Feb 9, 2026 · Form 4
- Sold 75 shares at $780.06 on Feb 9, 2026 · Form 4
- Sold 26 shares at $781.37 on Feb 9, 2026 · Form 4
- Sold 37 shares at $782.67 on Feb 9, 2026 · Form 4
- Sold 144 shares at $783.23 on Feb 9, 2026 · Form 4
- Sold 1 shares at $784.66 on Feb 9, 2026 · Form 4
- Sold 53 shares at $785.72 on Feb 9, 2026 · Form 4
Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Zoetis ZTS public float $69.2B, Jun 30, 2025
- Idexx Laboratories IDXX public float $42.9B, Jun 30, 2025
- Alnylam Pharmaceuticals ALNY public float $42.6B, Jun 30, 2025
- Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025
- Gilead Sciences GILD public float $103.2B, Jun 30, 2025